Illegal Drug Policy

The Enforcement-Treatment Nexus—should the United States criminalize drug possession and use, decriminalize it while expanding treatment, or adopt a hybrid model that leverages criminal justice consequences to compel treatment entry?

This question confronts a fundamental tension in American drug policy: the chronic failure of pure criminalization to reduce addiction and death, versus the demonstrable failure of decriminalization without enforcement leverage to connect addicted individuals—particularly homeless and severely impaired users—to treatment services.

Oregon’s Measure 110 experiment, which decriminalized drug possession in 2021 only to be repealed in 2024, exemplifies the central policy challenge: How do you create sufficient consequences to motivate treatment entry among people whose addiction has destroyed their capacity for voluntary help-seeking, without returning to the mass incarceration and racial disparities of the War on Drugs?

The stakes are immense – it is estimated that incarceration costs in the U.S. relating to non-violent drug offenders is ~$50 billion per year.

Over 107,000 Americans died from drug overdoses in 2023, with fentanyl driving unprecedented mortality. Visible street drug use and homeless encampments have created public disorder crises in major cities. Yet the United States incarcerates more people for drug offenses than any nation on earth, with profound racial disparities: Black Americans are 5-7 times more likely to be arrested for drug offenses despite using drugs at similar rates to whites. The question is not whether current policy works—it manifestly does not—but which direction of reform offers the best chance to reduce death, disease, crime, and suffering.

The Founding Era: Medical Use Without Prohibition

The Founding Fathers lived in an era when opiates were widely used as medicine, with no stigma or legal prohibition. Thomas Jefferson grew opium poppies at Monticello and relied on laudanum (a tincture of opium and alcohol) to treat chronic diarrhea in his final years. In November 1825, Jefferson wrote that “with care and laudanum I may consider myself in what is to be my habitual state.” Benjamin Franklin used laudanum to treat gout and kidney stones in his later years, writing in 1790 that it had robbed him of his appetite. George Washington may have used laudanum for severe dental pain.

The Founders viewed opium medicinally, not recreationally, and saw no role for federal prohibition. Their constitutional philosophy emphasized limited federal power, with most police powers reserved to the states. Benjamin Rush, a signer of the Declaration of Independence and prominent physician, published “An Inquiry Into the Effects of Ardent Spirits on the Human Mind and Body” in 1784, identifying alcoholism as a progressive disease—one of the first such characterizations in medical history. Interestingly, Rush believed opium might be safer than “spirituous liquors” and suggested addicts might substitute opium for alcohol. This reflected the 18th-century medical view that substance problems were matters of individual health and moral discipline, not criminal justice.

The Constitution grants Congress no explicit power to regulate drugs. The Commerce Clause would eventually be interpreted broadly enough to permit federal drug laws, but the Founders would likely have viewed drug prohibition as a state matter—if they considered it at all—rather than a federal concern.

America’s First Opioid Epidemic: 1865-1914

The Civil War catalyzed America’s first opioid epidemic. The Union Army alone distributed nearly 10 million opium pills, plus 2.8 million ounces of opium powders and tinctures, to treat battlefield injuries. Many soldiers returned home addicted. The invention of the hypodermic syringe in the 1850s made morphine injection common, and doctors freely prescribed opiates for everything from menstrual cramps to morning sickness to “diseases of a nervous character.” By the 1880s, women comprised more than 60% of opium addicts, as male physicians liberally prescribed morphine for female patients’ reproductive and “nervous” complaints.

Laudanum was cheaper than alcohol and available without prescription at any drugstore. It became a standard household remedy, and mothers routinely gave it to teething children or used it to put children to sleep. One 1858 report described a New England woman who drugged her children with laudanum so she could attend nightly prayer meetings. Medical journals warned of addiction dangers starting in the 1870s, but doctors had few alternatives for pain management, and rural physicians often never received the warnings.

Between 1898 and 1902, the opium and morphine business more than doubled. Addiction rates reached nearly three times the mid-1990s level. Yet addiction was not a criminal matter—it was a medical and moral concern.

The Opium Wars: Britain’s State-Sponsored Drug Trafficking (1839-1860)

Before examining America’s own drug prohibition history, it’s essential to understand how Western powers—particularly Britain—forcibly imposed opium addiction on China, an historical irony that haunts today’s fentanyl crisis.

In the early 19th century, Britain faced a massive trade deficit with China. British consumers craved Chinese tea, silk, and porcelain, but China had little interest in British manufactured goods, demanding payment in silver instead. Britain’s silver reserves were draining away. The British East India Company found the solution: opium grown in British-controlled India. By flooding China with opium, Britain could reverse the trade imbalance—Chinese silver would flow to Britain to purchase the addictive drug, which would then purchase Chinese goods.

By the 1830s, millions of Chinese were addicted to opium. The social devastation was immense: families destroyed, productivity collapsed, and silver—China’s monetary base—hemorrhaged out of the country. In 1839, the Daoguang Emperor appointed Commissioner Lin Zexu to halt the opium trade. Lin wrote an impassioned letter to Queen Victoria appealing to her moral responsibility: “Your Majesty has not before been thus officially notified, and you may plead ignorance of the severity of our laws, but I now give my assurance that we mean to cut this harmful drug forever.” The letter never reached the Queen.

Lin seized and publicly destroyed over 1,400 tons of opium (more than 20,000 chests) held by British merchants at Canton. The British government’s response was not to apologize for poisoning millions—it was to send warships.

The First Opium War (1839-1842) saw British naval forces, using superior military technology, inflict devastating defeats on Chinese forces. The Treaty of Nanking forced China to:

• ↳ Pay massive reparations to Britain for the destroyed opium
• ↳ Cede Hong Kong Island to Britain “in perpetuity”
• ↳ Open five “treaty ports” to British trade (including unrestricted opium sales)
• ↳ Grant extraterritoriality—British subjects in China could only be tried in British courts

When Britain demanded even more concessions, including explicit legalization of opium, the Second Opium War (1856-1860) erupted. Britain and France together defeated China, forcing the Treaty of Tientsin, which:

• ↳ Legalized the opium trade throughout China
• ↳ Opened more ports and the interior to foreign penetration
• ↳ Ceded Kowloon (next to Hong Kong) to Britain
• ↳ Granted foreigners additional rights and protections

Britain had waged two wars—killing thousands—for the “right” to addict millions of Chinese to opium and profit from their suffering. By the end of the Second Opium War, opium imports to China reached 50,000-60,000 chests annually and continued growing for three more decades. It is estimated that by the early 20th century, approximately 25% of China’s adult male population was addicted to opium.

This period became known in China as the beginning of the “Century of Humiliation”—a time when foreign powers swarmed over a weakened, drug-addled China, extracting concessions, territory, and wealth. The Qing Dynasty never recovered its strength. The Communist Party, when it took power in 1949, made eliminating opium addiction a cornerstone policy, using brutal methods to achieve what they claimed was China’s liberation from foreign-imposed drug addiction.

The Historical Irony and Today’s Fentanyl Crisis:

Fast forward 180 years. China is now the world’s primary source of precursor chemicals used to manufacture fentanyl—the synthetic opioid that killed approximately 75,000 Americans in 2023. Chinese chemical companies, operating in lightly regulated industries, supply precursors to Mexican cartels, who manufacture fentanyl and smuggle it into the United States. The result: fentanyl has become the leading cause of death for Americans aged 18-45, with approximately 200 people dying daily from overdoses.

The United States now finds itself pleading with China to restrict these chemical exports—to cooperate in stopping a drug crisis devastating American communities. Some observers have labeled this the “Reverse Opium War”—China now floods America with the chemicals of addiction, just as Britain once flooded China.

Is this deliberate revenge? The evidence is mixed. Some analysts note that:

• ↳ The Chinese Communist Party teaches schoolchildren that the Opium Wars represent the beginning of China’s “century of humiliation,” with Britain’s drug trafficking as the ultimate imperial crime.
• ↳ Chinese Ambassador Qin Gang explicitly referenced this history in 2022, noting that “with such searing pains in our national memory, China holds an understandably stronger antipathy for narcotics than any other country.”
• ↳ Yet China has been slow to schedule fentanyl precursors and reluctant to crack down on chemical companies, despite U.S. pleas.
• ↳ Some Chinese officials may view the fentanyl crisis as America’s problem—why should China spend resources controlling exports of legal chemicals just because Americans misuse them?

Others argue there’s no evidence of deliberate state policy to poison Americans, noting that:

• ↳ The chemicals have legitimate industrial uses, making control complex.
• ↳ China faces the same challenges the U.S. did with the “war on drugs”—a lucrative trade that’s difficult to suppress.
• ↳ Under the Biden administration, China did agree to schedule some precursors and resumed counternarcotics cooperation after a San Francisco summit in November 2023.
• ↳ The Trump administration has taken a more confrontational approach, imposing tariffs and accusing China of deliberately enabling the trade.

Regardless of intent, the historical parallel is striking: The nation that America helped liberate from Japanese occupation in World War II—at the cost of tens of thousands of American lives—now finds itself accused of facilitating a drug crisis that kills 200 Americans daily. And when the U.S. demands Chinese cooperation, some Chinese officials must surely remember Commissioner Lin Zexu’s unanswered letter to Queen Victoria pleading for Britain to stop poisoning Chinese citizens.

The lesson: Drug trafficking as an instrument of trade policy, profit, or geopolitical competition has devastating human consequences that echo across generations. Britain’s opium trafficking helped destroy the Qing Dynasty and contributed to over a century of Chinese suffering. Today’s fentanyl crisis, whether through deliberate policy or malign neglect, is destroying American families and communities at an unprecedented scale.

This historical context makes America’s moral position complicated: How do we demand Chinese cooperation in stopping drug exports when our own nation was founded during an era when Western powers waged wars to force drug imports onto China? The irony is not lost on Chinese officials—or on historians studying both crises.

The Shift to Criminalization: Racism and Progressive Reform (1909-1937)

Federal drug prohibition in the United States emerged from a toxic mixture of racial anxiety, colonial policy, and Progressive-era reform. Chinese immigrants had brought opium smoking to the United States, operating opium dens in major cities. These establishments attracted white working-class men and Chinese immigrants, creating moral panic about racial mixing. As historian David Courtwright observed, “As long as the most common kind of narcotic addict was a sick old lady, a morphine or opium user, people weren’t really interested in throwing them in jail.” But when opium smoking became associated with Chinese immigrants and white urban poor, prohibition gained political traction.

The Spanish-American War gave America control of the Philippines, where a thriving opium trade existed. President Theodore Roosevelt, urged by American missionaries alarmed by the trade, called for an international opium commission in Shanghai. The United States needed domestic legislation to credibly advocate reform abroad. In 1909, Congress passed the Opium Exclusion Act, banning the import of opium prepared for smoking and targeting the practice specifically associated with Chinese users.

The Harrison Narcotics Tax Act of 1914 required registration and taxation of opium and coca production, import, and distribution. While technically a revenue measure (to satisfy constitutional concerns), it effectively criminalized non-medical drug use. The law allowed physicians to prescribe opiates “in the course of professional practice only”—a phrase federal authorities interpreted narrowly to exclude long-term maintenance prescribing for addiction. Doctors who continued prescribing to addicted patients faced prosecution; by 1938, over 25,000 physicians had been arrested.

Marijuana prohibition followed a similar pattern of racial scapegoating. Cannabis had been known as “reefer” but was rebranded “marijuana” to associate it with Mexican migrants arriving during the 1930s. Harry Anslinger, head of the Federal Bureau of Narcotics, promoted marijuana prohibition with overtly racist rhetoric, claiming it led to interracial relationships and violence. The Marijuana Tax Act of 1937 effectively criminalized cannabis nationwide.

Nixon’s “War on Drugs”: Treatment First, Then Punishment (1970-1974)

On June 17, 1971, President Richard Nixon declared drug abuse “public enemy number one” and launched a “war on drugs.” But Nixon’s approach, contrary to popular belief, emphasized treatment over incarceration. The 1970 Comprehensive Drug Abuse Prevention and Control Act actually repealed many mandatory minimum sentences, reduced simple possession from a felony to a misdemeanor, and gave judges latitude to assign probation or dismissal. The law authorized substantial funding for the Department of Health, Education and Welfare to provide treatment, rehabilitation, and education.

Nixon created the Special Action Office for Drug Abuse Prevention (SAODAP) and spent more money on treatment than on criminal justice responses. He could be nicknamed “the methadone president” for his expansion of methadone maintenance programs. During Nixon’s five and a half years in office, the prison population increased only 16.7%.

John Ehrlichman, Nixon’s domestic policy adviser, later admitted in a 1994 interview published by Harper’s Magazine in 2016 that the drug war had a political motive: “The Nixon campaign in 1968, and the Nixon White House after that, had two enemies: the antiwar left and Black people. You understand what I’m saying? We knew we couldn’t make it illegal to be either against the war or Black, but by getting the public to associate the hippies with marijuana and Blacks with heroin, and then criminalizing both heavily, we could disrupt those communities. We could arrest their leaders, raid their homes, break up their meetings, and vilify them night after night on the evening news. Did we know we were lying about the drugs? Of course we did.”

Despite this cynical origin, Nixon’s policies were comparatively humane. His successors would transform the drug war into an engine of mass incarceration.

Reagan’s Revolution: Mass Incarceration and Racial Disparity (1981-1989)

Ronald Reagan fundamentally transformed American drug policy. Shortly after taking office in 1981, Reagan announced: “We’re taking down the surrender flag that has flown over so many drug efforts; we’re running up a battle flag.” He reversed Nixon’s treatment emphasis, slashing treatment budgets while massively expanding enforcement.

The 1986 Anti-Drug Abuse Act, passed after basketball star Len Bias’s cocaine-related death, appropriated $1.7 billion for enforcement and established 29 new mandatory minimum sentences—more than the entire country had seen in its prior history combined. The law created the infamous 100:1 sentencing disparity between crack and powder cocaine: possession of 5 grams of crack triggered a mandatory five-year sentence, while 500 grams of powder cocaine were required for the same penalty. Since approximately 80% of crack users were Black while powder cocaine was more common among whites, this disparity drove an explosion in Black incarceration.

The 1988 Anti-Drug Abuse Act doubled down, creating mandatory minimums for mere possession of crack (not just distribution) and reinstating the federal death penalty for certain drug-related crimes.

Between 1980 and 1997, the number of people incarcerated for nonviolent drug offenses exploded from 50,000 to 400,000. The Black incarceration rate jumped from about 600 per 100,000 people in 1970 to 1,808 in 2000. The U.S. prison population overall grew from 240,593 in 1975 to 1.43 million in 2019, with about one in five prisoners incarcerated with a drug offense as their most serious crime.

The New Jim Crow: Collateral Consequences and Racial Targeting

The ACLU’s 2001 report “The Drug War is the New Jim Crow” documented that while “whites and blacks use drugs at almost exactly the same rates … African-Americans are admitted to state prisons at a rate that is 13.4 times greater than whites, a disparity driven largely by the grossly racial targeting of drug laws.” Michelle Alexander’s 2010 book The New Jim Crow: Mass Incarceration in the Age of Colorblindness expanded this analysis, documenting how drug convictions stripped people of voting rights, educational assistance, public housing eligibility, child custody, and employment opportunities—creating a permanent underclass.

A 2006 ACLU analysis found that the average federal drug sentence for African Americans rose from 11% higher than whites before the 1986 law to 49% higher by 1990. These disparities persisted despite identical rates of drug use across racial groups.

President Bill Clinton continued the punitive approach with his 1994 Crime Bill, which provided $30 billion for state prisons, mandated life sentences via three-strikes laws, and added 60 new death penalty crimes. His administration rejected the U.S. Sentencing Commission’s recommendation to eliminate crack-powder sentencing disparities.

Recent Reforms: Modest Retreat (2010-Present)

The 2010 Fair Sentencing Act reduced the crack-powder disparity from 100:1 to 18:1—a significant improvement, but still preserving racially disparate punishment. The Obama administration avoided using the term “war on drugs,” favoring “smart on crime” approaches, but enforcement remained robust.

State-level reforms have been more dramatic. As of 2025, 24 states and Washington D.C. have legalized recreational marijuana, and 38 states permit medical use. Several states have reduced penalties for possession of other drugs or implemented pre-arrest diversion programs. But these reforms remain patchwork, and fentanyl’s emergence has created new pressure for aggressive enforcement.

Oregon’s Measure 110: The Promise and Failure of Decriminalization (2021-2024)

In November 2020, Oregon voters approved Ballot Measure 110 with 58% support, making Oregon the first state to decriminalize possession of small amounts of all drugs—heroin, methamphetamine, cocaine, and fentanyl. The measure replaced criminal penalties with $100 fines (waived if the recipient called a treatment hotline) and dedicated marijuana tax revenue and law enforcement savings to fund treatment expansion.

The theory was compelling: treat addiction as a health issue rather than a criminal one, remove the fear and stigma of arrest, expand treatment capacity, and create easier pathways to recovery. Police would issue citations with treatment information rather than making arrests.

The implementation was catastrophic.

Portland Police Sergeant Jerry Cioeta’s experience captured the core problem: His bike squad issued over 700 citations in one year, and “exactly two people” called the treatment hotline. The $100 fine went unpaid, the citation was ignored, and nothing happened. As one officer put it: “We’ve talked to exactly two people that have actually called that number … and got absolutely nowhere with it.”

The fundamental flaw was identified by Senator Michael Dembrow, a Portland Democrat who opposed repealing Measure 110: “The fundamental flaw with Ballot Measure 110 was that it decriminalized first and only slowly funded, designed and implemented the needed treatment programs.” Treatment capacity remained inadequate, and most critically, there was no leverage to connect people to treatment.

Between 2001 and 2024, police issued more than 9,700 citations for drug possession—and more than 1,200 people received multiple citations, suggesting repeat encounters with no intervention. Only 9% of cases with citations also involved other violations; the other 91% were simple possession cases where police had no tools beyond a ticket the person would ignore.

Overdose deaths, already rising, continued their trajectory. Drug-related deaths increased during Measure 110’s implementation, though advocates noted this matched trends in neighboring states facing the same fentanyl crisis. More visible was the explosion of open-air drug use, homeless encampments, and public disorder—especially in downtown Portland. Mayor Ted Wheeler testified: “The last time I saw somebody consuming what I believe to be fentanyl publicly on our streets was less than five minutes ago, three blocks from City Hall.”

Assistant Multnomah County Prosecutor Nathan Vasquez told of his son wearing a backpack on the front of his body during walks to school in downtown Portland “to guard against a man waving around a heroin needle,” asking: “How did we get to the point where our children have to use their backpacks as shields to walk to school?”

Public opinion turned decisively against Measure 110. In February 2024, House Minority Leader Jeff Helfrich, a former Portland police sergeant, declared: “Measure 110 has failed. We can see it on the streets. We can see it in the statistics. We can hear it in the voices of the victims.”

In March 2024, the Oregon legislature passed House Bill 4002 with overwhelming bipartisan support (51-7 in the House, 21-8 in the Senate), recriminalizing drug possession as a misdemeanor. The law took effect September 1, 2024. Governor Tina Kotek signed it, noting: “One piece will be criminalization, but if we just look at criminalization in isolation, I think it’s missing the point.”

The lesson was not that decriminalization is inherently wrong—it’s that decriminalization without meaningful consequences and without adequate treatment capacity creates a void where nothing happens. As one drug policy expert noted: “We still suck at access to voluntary treatment. We need a vast voluntary system, so that people can engage with treatment when they want it.” The question Oregon’s failure poses is this: What homeless person on drugs has the clarity and acuity to seek self-help voluntarily? Without leverage—consequences that motivate treatment entry—many severely addicted individuals simply continue using until they die.

Drug Courts and Coerced Treatment: Evidence of Effectiveness

While Oregon’s experiment failed, another model has accumulated substantial evidence: drug courts, which use the leverage of criminal sanctions to compel treatment entry and monitor compliance.

Drug courts operate on a simple premise: instead of prison, offer treatment—but with teeth. Participants must complete rigorous treatment programs, submit to frequent drug testing, and appear regularly before a judge. Compliance brings rewards and reduced charges; non-compliance brings escalating sanctions, ultimately including jail time if all else fails.

The evidence is striking:

• ↳ Completion rates: 84% of individuals who completed drug court programs were neither arrested nor charged with any significant crime in the first year after graduation—a dramatic reduction in recidivism.
• ↳ Effectiveness of mandated treatment: A comprehensive review of 11 studies found that five reported positive relationships between legal coercion and treatment outcomes, four reported no difference, and only two reported negative relationships. Most research shows that legally referred clients do as well or better than voluntary clients in and after treatment.
• ↳ Cost savings: Drug courts save an average of $5,680-$6,208 per person compared to incarceration, and it costs approximately $8,000 per year to provide treatment through drug court versus $45,000 to incarcerate the same person.
• ↳ Treatment retention: Legally mandated clients show significantly better retention in treatment. Patients entering residential treatment with moderate to high legal pressure were significantly more likely to stay in treatment for the critical 90+ days needed for lasting change.

The research on coerced treatment reveals a counterintuitive finding: motivation doesn’t have to come first; it can emerge during treatment. Many offenders, even when court-mandated, report wanting treatment and being ready to change—the external pressure simply got them through the door. As one addiction expert noted: “Many offenders actually want treatment, even if they are court mandated to go.”

Critics rightly worry about coercion’s ethical dimensions and effectiveness limitations. The UN Office on Drugs and Crime has stated that “mandatory treatment settings do not represent a favorable or effective environment for the treatment of drug dependence.” Two of the 11 studies did find worse outcomes with coercion, particularly in programs where more than 75% of patients were court-mandated, suggesting that high concentrations of reluctant clients can undermine therapeutic environments.

But the bulk of evidence suggests that the leverage of potential criminal consequences can save lives by connecting people to treatment they would not otherwise seek—and that once in treatment, many discover genuine motivation for recovery.

Portugal: The Success Story—And Its Nuances

Portugal is often cited as proof that decriminalization works. In 2001, facing Europe’s worst heroin epidemic, Portugal decriminalized personal possession of all drugs while massively expanding treatment and harm reduction services.

The results were genuinely impressive:

• ↳ Overdose deaths: Dropped 80% from 1999 to 2018, giving Portugal one of the lowest drug-related death rates in Western Europe—one-tenth of Britain’s and one-fiftieth of the United States’.
• HIV infections: New HIV diagnoses among drug users declined by 90%, falling from 104.2 cases per million in 2000 to 13.4 in 2009.
• ↳ Treatment engagement: A roughly 60% increase in treatment uptake by 2012.
• Youth drug use: Consistently below the European average for 20 years, particularly among 15-34-year-olds.
• Prison population: Significantly reduced, easing the burden on the criminal justice system.

But Portugal did not simply decriminalize and walk away. The policy had four critical components:

1. Decriminalization with consequences: Possession remains illegal—just not criminal. People caught with drugs face administrative penalties (fines, community service) decided by “Commissions for the Dissuasion of Drug Addiction”—panels of legal, health, and social work professionals. In 90% of cases, no penalty is applied if drug use appears non-problematic. But the system maintains leverage.
2. Massive treatment expansion: Portugal invested heavily in low-threshold methadone programs, supervised consumption rooms, needle exchanges, housing for drug users, and wraparound services. Treatment became widely accessible, affordable, and destigmatized.
3. Mobile treatment teams: Professional teams provided street-level care, testing, syringe exchange, and treatment referrals where users were, removing barriers to service access.
4. Comprehensive harm reduction: Recognizing that not everyone is ready to quit, Portugal provided services to reduce death and disease even for active users: safe consumption spaces, pharmaceutical-grade supplies, health care, and social support.

Oregon tried to copy Portugal’s decriminalization but failed to implement Portugal’s treatment infrastructure first. As one expert put it, Oregon “decriminalized first and only slowly funded, designed and implemented the needed treatment programs.” Portugal, by contrast, built the system alongside decriminalization.

Moreover, Portugal’s success has become more complex recently. From 2019-2022, overdose deaths doubled in Lisbon and reached a 12-year national high. Drug use among adults rose from 7.8% in 2001 to 12.8% in 2022. Crime increased 14%, and drug encampments appeared—developments that were European rarities. Some Portuguese policymakers and police have reported system fatigue: demoralized officers no longer citing users, Non-Governmental Organizations (NGOs) framing lifetime drug use as a right rather than encouraging treatment, and a fragmenting system.

The lesson: Portugal’s model works when fully implemented with adequate resources and systemic commitment—but it is not self-sustaining, and it requires continuous investment and attention.

Switzerland: Heroin-Assisted Treatment and Supervised Consumption

Switzerland pioneered perhaps the most radical harm reduction approach: prescribing pharmaceutical-grade heroin to severely addicted users who have failed conventional treatment multiple times.

Beginning in 1994, Switzerland opened heroin-assisted treatment (HAT) clinics where long-term users could inject medical-grade heroin under supervision, combined with comprehensive medical and social services. The program was rigorously evaluated and proved remarkably successful:

• ↳ Crime reduction: Clear and substantial decreases in criminal activity among participants.
• ↳ Health improvements: Constant improvement in participants’ physical and mental health.
• ↳ Overdose prevention: Dramatic reduction in overdose deaths; participants receive known doses of pure heroin in safe settings.
• ↳ Social stabilization: Marked improvement in employment and housing stability.
• ↳ Treatment transition: Many participants eventually transition to conventional treatment or reduce use.

By 2021, approximately 1,700 people received HAT in 22 Swiss centers. After strong public approval through referenda, the federal government made HAT a regular treatment option in 1999. The program has been replicated in Germany, the Netherlands, Canada, Denmark, Spain, and the United Kingdom.

Switzerland also operates 12 supervised consumption sites where users can inject drugs they bring (not provided by the facility) under medical supervision with sterile equipment. These sites have lowered disease transmission and overdose deaths.

The Swiss model rests on a radical premise: for some severely addicted individuals, providing pharmaceutical heroin in a controlled setting produces better outcomes than any enforcement or treatment alternative. It recognizes that abstinence may not be achievable for everyone, but harm can still be reduced.

Critics note this approach is politically controversial and expensive, requires significant infrastructure and medical staffing, and may not translate to the U.S. context given different drug cultures and regulatory environments. But Switzerland’s 30-year experiment demonstrates that unconventional approaches can work when properly implemented and sustained.

Fiscal conservatives approach illegal drug policy from two primary positions: those emphasizing the costs of enforcement and incarceration, and those emphasizing the costs of addiction’s social consequences.

The Economic Case Against the War on Drugs

The financial burden is staggering: since Nixon declared the “war on drugs” in 1971, the United States has spent over $1 trillion on enforcement—$47 billion in 2020 alone. This spending has produced mass incarceration (2.3 million people behind bars, many for drug offenses), with incarceration costing $35,000-$75,000 per person annually.

Drug enforcement consumes enormous state and local resources: police time, court dockets, public defenders, prosecutors, jails, prisons, probation, and parole. The opportunity cost is immense—resources that could address violent crime, property crime, infrastructure, or education are instead spent processing nonviolent drug offenders.

The racial disparities create additional social costs through broken families, lost economic potential, and communities stripped of working-age adults. Mass incarceration has devastating effects on children, employment prospects, and civic participation.

Treatment is dramatically cheaper than incarceration. Drug court programs cost approximately $8,000 per person annually versus $45,000 for incarceration, and produce better outcomes. Methadone treatment costs roughly $4,700 annually per patient; heroin-assisted treatment in Switzerland costs less than $10 per citizen per year while generating societal cost savings (reduced health care, legal costs, lost income) of 12-18%.

Some fiscal conservatives advocate full legalization and taxation, modeled on cannabis legalization in states like Colorado and Washington. Legal cannabis markets generate substantial tax revenue while eliminating enforcement costs and freeing police to address serious crime. Applying this model to other drugs could theoretically generate revenue while slashing criminal justice expenditures.

The Economic Case for Enforcement and Treatment Leverage

Other fiscal conservatives emphasize the profound costs of drug addiction itself: lost productivity, healthcare costs, crime victimization, child neglect, foster care systems overwhelmed by parental addiction, emergency room costs, and social services strain.

From this perspective, effective intervention prevents costs. If criminal justice leverage gets addicted individuals into treatment they wouldn’t otherwise seek, and that treatment produces recovery, society saves on all the downstream costs of continued addiction: medical emergencies, property crime, law enforcement response, incarceration of addicts who commit crimes to fund drug use, and child protective services.

Drug courts, from this view, represent smart fiscal policy: they’re cheaper than incarceration while more effective at reducing recidivism. The savings multiply over time as participants stabilize, find employment, pay taxes, and stop generating enforcement and emergency service costs.

The Oregon Measure 110 experience reinforces this view: decriminalization without consequences simply allowed addiction to persist, generating continued costs in emergency services, public health, business impacts from street disorder, tourism losses, and quality of life degradation that suppresses property values and economic activity.

Internal Tensions Among Fiscal Conservatives

Libertarian-leaning conservatives favor decriminalization or legalization on freedom grounds, viewing drug use as a personal choice where government should not intrude. They emphasize the waste of the drug war, the corruption it enables, and the distortion of police priorities. They’re skeptical that government-run treatment programs deliver value and worry about coercion’s ethical implications.

Social conservatives and law-and-order advocates view drug use as morally wrong and socially destructive, justifying government intervention. They prioritize public order, community standards, and protecting children from drug culture normalization. They support enforcement paired with treatment rather than pure decriminalization, fearing that eliminating consequences enables addiction.

Fiscal hawks simply want cost-effective policy regardless of ideological preference. They note that neither pure enforcement nor pure decriminalization has worked well in practice. They seek evidence-based approaches—and the evidence suggests some form of leverage (whether criminal or civil consequences) combined with accessible treatment produces the best return on investment.

The debate centers on whether reduced enforcement costs from decriminalization outweigh the social costs of unaddressed addiction, and whether the leverage of criminal consequences is necessary to achieve treatment outcomes that prevent long-term costs.

Progressive advocates approach drug policy through lenses of racial justice, public health, harm reduction, and skepticism toward punishment.

The Racial Justice Imperative

For progressives, the war on drugs represents one of America’s most profound civil rights failures since Jim Crow. Michelle Alexander’s framework of “The New Jim Crow” captures this view: drug prohibition has been weaponized to disproportionately incarcerate, disenfranchise, and marginalize Black and Latino Americans.

The statistics are damning:

• ↳ Black Americans are 5-7 times more likely to be arrested for drug offenses despite using drugs at virtually identical rates to whites.
• ↳ The crack-powder cocaine sentencing disparity (even reduced to 18:1) continues to produce racially disparate punishments.
• ↳ Drug convictions strip people of voting rights, public housing, educational aid, and employment prospects—creating a permanent underclass.
• ↳ In Portland, Black people received 4.6% of Measure 110 citations while comprising only 2.3% of Oregon’s population, demonstrating that racial targeting persists even under decriminalization.

John Ehrlichman’s admission that Nixon’s drug war explicitly targeted Black communities and anti-war activists confirms what many had long suspected: prohibition has often been a tool of racial and political control rather than public health.

From this perspective, any reform that increases criminal justice involvement risks perpetuating racial injustice. Even seemingly benign approaches like drug courts can become mechanisms for enhanced surveillance and control of communities of color.

The Public Health Model

Progressives argue that addiction is fundamentally a health condition, not a moral failing or criminal behavior. Treatment, not punishment, should be the primary response. Criminalizing addiction is like criminalizing diabetes or cancer—it’s incoherent and counterproductive.

The public health approach emphasizes:

1. Treatment on demand: Making treatment services widely available, affordable, and destigmatized so people can access help when ready.
2. Harm reduction: Recognizing that not everyone is ready to quit, but death and disease can still be prevented through needle exchanges, supervised consumption sites, fentanyl test strips, naloxone distribution, and pharmaceutical-grade supplies.
3. Social determinants: Addressing the root causes of addiction—trauma, poverty, lack of opportunity, mental illness—rather than just treating symptoms.
4. Destigmatization: Removing shame and fear that prevent people from seeking help.

Portugal’s success is often cited as validation: treating drug use as a health matter while expanding services produced dramatic reductions in death, disease, and social harm.

The Critique of Coercion

Many progressives are deeply uncomfortable with using criminal justice leverage to compel treatment. They raise several concerns:

↳ Philosophical: Addiction treatment requires motivation, honesty, and vulnerability—qualities difficult to achieve under threat of punishment. Coercion may produce superficial compliance while undermining genuine recovery.

↳ Effectiveness: The UN Office on Drugs and Crime’s position that “mandatory treatment settings do not represent a favorable or effective environment” resonates with progressives who question whether coerced treatment actually works.

↳ Discrimination: Legal systems don’t mandate treatment equally. Black people are less likely to be offered diversion programs than whites, meaning coerced treatment risks becoming another mechanism of racial disparity—white offenders get treatment; Black offenders get prison.

↳ System strain: Drug courts and mandated treatment programs overwhelm already stretched courts, treatment providers, and social services, potentially degrading quality for everyone.

The Oregon Conundrum: Progressives Divided

Oregon’s Measure 110 failure created a painful split among progressives:

Harm reduction progressives argue that Measure 110 failed not because decriminalization was wrong, but because implementation was botched. They point out that:

• ↳ Treatment capacity wasn’t built before decriminalization launched.
• ↳ The fentanyl crisis would have caused deaths regardless of policy.
• ↳ Recriminalization will return to racist mass incarceration without solving the underlying problem.
• ↳ Alternative approaches exist: civil (not criminal) consequences, outreach workers rather than police, better-funded voluntary treatment.

As Jackie Yerby of the ACLU of Oregon testified: “We need to invest in more peer support, more treatment, more support. Not jails.”

Pragmatic progressives acknowledge that without some form of leverage—consequences that motivate change—many severely addicted individuals won’t engage with services. They saw Measure 110’s failure to create any meaningful pathway from police contact to treatment, noting that homeless individuals in active addiction often lack capacity for voluntary help-seeking.

This faction supports “deflection” programs (pioneered in places like Seattle’s LEAD program) where police refer people to services with follow-up but short of arrest, or civil (not criminal) consequences paired with treatment mandates. They seek middle ground between criminalization and pure decriminalization-without-leverage.

Internal Tensions Among Progressives

Radical harm reductionists view any form of coercion or consequence as unacceptable, arguing that true harm reduction meets people where they are without judgment or force. They prioritize individual autonomy and bodily freedom, viewing drug use (even problematic use) as a human right. They emphasize safe supply, supervised consumption, and services without preconditions.

Public health progressives accept that some external motivation may be necessary to engage severely impaired individuals in treatment, but insist it should come through public health systems (civil citations, health department interventions) rather than criminal justice. They’re willing to impose consequences—but not criminal ones.

Pragmatic progressives recognize that criminal justice systems already interact with drug users and may provide the most realistic mechanism for treatment referral in many jurisdictions. They support reform—ending incarceration for possession, eliminating racial disparities, expanding treatment—while maintaining some sanctions to create leverage. They’d prefer alternatives, but accept that perfectly built-out public health systems don’t exist and may never materialize.

The core tension: How do you help people who cannot or will not help themselves without resorting to coercion—and if some coercion proves necessary, how do you prevent it from becoming another system of racial control?

The evidence suggests that neither pure criminalization nor pure decriminalization without consequences produces good outcomes. A synthesis approach might include:

The Three-Tiered Model

Tier 1: Decriminalize Possession, Mandate Deflection

• ↳ Possession of small amounts (personal use) is not a criminal offense but triggers administrative consequences.
• ↳ Police or outreach workers refer individuals to assessment within 72 hours.
• ↳ Failure to appear results in escalating civil (not criminal) fines and potential civil contempt.
• ↳ Goal: Remove criminal records and incarceration while maintaining leverage for engagement.

Tier 2: Treatment-Focused Intervention

• ↳ Assessment determines treatment needs; individuals are offered a plan.
• ↳ Accepting treatment results in no further consequences.
• ↳ Treatment programs are adequately funded, accessible, evidence-based, and culturally competent.
• ↳ Success in treatment clears all citations and fines.
• ↳ Goal: Connect people to help while removing barriers.

Tier 3: Progressive Consequences for Non-Engagement

• ↳ Refusing assessment or treatment triggers escalating civil sanctions: increasing fines, driver’s license suspension, restrictions on professional licenses, potential civil contempt with short-term holds.
• ↳ Criminal charges remain possible for: possession with intent to distribute, drug-related crimes (theft, violence), repeated violations after extensive intervention attempts.
• ↳ Goal: Maintain sufficient leverage to motivate participation without mass incarceration.

The Support Infrastructure

This model only works with adequate funding for:

1. Immediate-access treatment: Beds available within days, not months. Medication-assisted treatment (methadone, buprenorphine, naltrexone) widely available.
2. Housing-first approaches: Recognizing that stable housing enables recovery.
3. Harm reduction services: Supervised consumption sites, clean supplies, fentanyl testing, naloxone distribution.
4. Outreach teams: Mobile units providing street-level care, building trust, connecting people to services.
5. Recovery support: Peer support, employment assistance, family reunification services, mental health treatment.

The Racial Equity Mandate

Any reform must include:

• ↳ Independent monitoring of racial disparities in referrals, sanctions, and treatment access.
• ↳ Consequences for discriminatory enforcement: Jurisdictions showing racial disparities lose access to federal funding.
• ↳ Community oversight: Civilian review boards with power to investigate and sanction discriminatory practices.
• ↳ Expungement: Automatic clearing of past drug possession convictions.

The Federal-State Balance

• Federal government: Ends federal criminalization of simple possession, provides funding for treatment infrastructure, sets standards for evidence-based programs, monitors racial equity, regulates safe supply.
• State and local: Implement assessment and treatment systems, operate civil sanction mechanisms, fund services, experiment with approaches while meeting federal standards.

The Longer-Term Question

Portugal and Switzerland demonstrate that more radical approaches can work—but they require sustained political will, adequate funding, and comprehensive implementation. The United States might gradually move toward these models as evidence accumulates and public opinion shifts.

The immediate goal should be: Stop mass incarceration while creating leverage to connect people to treatment—recognizing that severely addicted individuals often lack capacity for voluntary help-seeking, but also recognizing that punishment without treatment accomplishes nothing.

Safeguards Against Policy Failures

Independent Evaluation Mandate

• ↳ Federal requirement for rigorous, ongoing evaluation of outcomes: overdose deaths, treatment engagement, recidivism, racial disparities, cost-effectiveness.
• ↳ Results published publicly and used to adjust implementation.
• ↳ Funding contingent on meeting benchmarks.

Racial Equity Monitoring

• ↳ Independent civil rights organizations review enforcement data quarterly.
• ↳ Jurisdictions showing unjustified racial disparities face federal intervention and funding loss. 
• ↳ Community oversight boards with subpoena power.

Treatment Quality Standards

• ↳ Evidence-based practice requirements for funded programs.
• ↳ Accreditation and regular audits of treatment providers.
• ↳ Patient outcomes tracking and transparency.
• ↳ Prohibition on predatory “treatment” scams.

Fiscal Accountability

• ↳ Treatment and harm reduction funding protected in dedicated accounts, not subject to legislative raids.
• ↳ Regular audits of spending efficiency.
• ↳ Cost-benefit analyses comparing investments to outcomes.

Rights Protections

Due Process

• ↳ Civil sanctions must include hearing rights, representation, and appeals.
• ↳ Clear standards for when civil consequences can escalate.
• ↳ Strict limits on contempt holds (days, not weeks or months).

Medical Privacy

• ↳ Treatment records protected; cannot be used for subsequent prosecution.
• ↳ Confidentiality between patients and providers.
• ↳ No mandatory reporting to law enforcement except for specific threats.

Voluntary Treatment Protection

• ↳ People seeking treatment voluntarily cannot face legal consequences for drug use disclosed during treatment.
• ↳ “Safe harbor” provisions encouraging help-seeking.

Legislative Reversibility

Sunset Provisions

• ↳ Major reforms include sunset clauses requiring reauthorization after 5-7 years based on evidence.
• ↳ Built-in evaluation periods before full implementation.

Emergency Reversal Authority

• ↳ If overdose deaths increase by specified thresholds, states can temporarily reinstate criminal penalties while reviewing implementation.
• ↳ Federal government can intervene if state implementations produce documented disasters.

Judicial Oversight

Constitutional Review

• ↳ Courts remain available to challenge discriminatory enforcement, coercive practices, or violations of rights.
• ↳ Class action litigation remains possible to address systemic failures.

Appellate Paths

• ↳ Clear routes to challenge civil sanctions, treatment mandates, and enforcement actions.

The illegal drug policy debate exposes a fundamental tension in American governance: How do we help people who cannot help themselves without becoming oppressive?

The Founding Fathers lived in an era when opiates were medicine, used without stigma or prohibition. Benjamin Franklin and Thomas Jefferson relied on laudanum; there were no “drug laws” because there was no concept of “drug criminalization.” The Constitution they crafted envisioned limited federal power, with most police authority residing in states.

Yet the Founders also understood human weakness and the need for social order. Benjamin Rush identified alcoholism as a disease requiring intervention. The Founders would likely have viewed severe addiction as a combination of moral failing, medical condition, and social problem—but they would have been skeptical of vast federal enforcement bureaucracies and mass incarceration as solutions.

The modern debate reflects competing visions of freedom and responsibility:

The libertarian vision sees drug use as a personal choice where government should not intrude. Adults own their bodies and bear responsibility for their decisions. Prohibition creates more harm than drugs themselves through black markets, violence, corruption, and eroded civil liberties.

The communitarian vision sees drug addiction as a social disease that destroys families, communities, and the social fabric. Society has both the right and duty to intervene—not primarily to punish, but to protect the vulnerable (including addicts themselves) and preserve community well-being.

The public health vision sees addiction as a medical condition requiring treatment, not judgment or punishment. Criminalization drives addiction underground, prevents help-seeking, and enables disease spread. Evidence-based treatment and harm reduction save lives and money.

The racial justice vision sees drug prohibition as a tool of oppression that has devastated Black and Latino communities. Any system involving law enforcement risks perpetuating discrimination. True reform requires ending criminalization and investing massively in community-based health solutions.

Oregon’s Measure 110 failure revealed an uncomfortable truth that challenges both progressive and conservative orthodoxy: Purely voluntary systems often fail to reach the most severely impaired individuals who need help most urgently. The homeless person on fentanyl, experiencing severe psychosis or cognitive impairment from drug use, often lacks the clarity to recognize the need for treatment or the capacity to seek it.

This creates the moral and practical dilemma at the heart of drug policy: Do we accept that some people will die because we respect their autonomy absolutely? Or do we intervene coercively, accepting the risk of overreach, discrimination, and the violation of liberty that coercion entails?

The Swiss and Portuguese models suggest a middle path: maintain leverage (through civil or administrative consequences, not necessarily criminal prosecution), but pair that leverage with genuinely helpful services—treatment that works, harm reduction that prevents death, support that addresses root causes. Make the “treatment path” so accessible, comprehensive, and destigmatized that the choice between consequences and recovery is genuine.

Drug courts demonstrate that legal leverage can work—but they also show the risks: disparate impact, coercion’s limitations, the danger of mass supervision replacing mass incarceration.

The question is not whether we should have zero consequences for drug use—Oregon’s experiment proved that doesn’t work. The question is: What kind of consequences, administered by whom, connected to what services safeguards against discrimination and abuse?

Fifty years of the War on Drugs taught us that punishment without treatment fails. Three years of Oregon’s Measure 110 taught us that decriminalization without consequences also fails.

The synthesis requires:

• ↳ Ending mass incarceration for drug possession
• ↳ Creating meaningful (but not criminal) leverage to connect people to services
• ↳ Building genuinely adequate treatment capacity first
• ↳ Implementing robust harm reduction
• ↳ Enforcing racial equity aggressively
• ↳ Accepting that some coercion may be necessary—while guarding against its abuse

This is uncomfortable territory. It requires accepting that perfect solutions don’t exist, that tradeoffs are real, and that the best approach may involve modest use of state power to save lives—while building in rigorous protections against overreach.

The Founders understood the tension between order and liberty. They built a system designed to accommodate competing values through federalism, checks and balances, and civic debate. The drug policy question is a modern manifestation of an ancient challenge: how do we create a society that is both free and good? How do we balance individual autonomy with collective responsibility?

There is no simple answer—but there are approaches that work better than others. The evidence suggests that meeting people where they are, with genuine help and modest pressure, saves more lives than either pure punishment or pure permissiveness. The question is whether America has the political will, the fiscal commitment, and the moral courage to implement such an approach—and to sustain it long enough to work.